These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32888823)

  • 1. Frequency and specificity of Red blood cell alloantibodies in multitransfused Egyptian patients with hematological and nonhematological malignancies.
    El Fetouh RMA; Elmoniem GMA; Allam RM; Sobeih ME; Kamel MM; Radwan SM
    Transfus Apher Sci; 2020 Dec; 59(6):102909. PubMed ID: 32888823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
    Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
    Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunizations following blood transfusions.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D; Balija M
    Acta Med Croatica; 1994; 48(4-5):193-7. PubMed ID: 7534524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications in the use of blood transfusions--alloimmunization in polytransfused patients].
    Rakić S; Belić B; Erceg S; Jovanović R; Kulić Z; Stefanović N; Belić A; Uzurov V; Spasojević J
    Med Pregl; 1999; 52(9-10):375-8. PubMed ID: 10624387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell alloimmunization in multitransfused patients in a tertiary care center in Western India.
    Philip J; Biswas AK; Hiregoudar S; Kushwaha N
    Lab Med; 2014; 45(4):324-30. PubMed ID: 25316664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of red-blood-cell and non-red-blood-cell-targeted autoantibodies in alloimmunized postpartum women.
    Schonewille H; van de Watering LMG; Oepkes D; Lopriore E; Cobbaert CM; Brand A
    Vox Sang; 2020 Nov; 115(8):783-789. PubMed ID: 32458481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of red blood cell alloimmunization in multitransfused thalassemic children of Jammu region.
    Dogra A; Sidhu M; Kapoor R; Kumar D
    Asian J Transfus Sci; 2015; 9(1):78-81. PubMed ID: 25722579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell alloimmunization in multitransfused HLA-typed patients.
    Brantley SG; Ramsey G
    Transfusion; 1988; 28(5):463-6. PubMed ID: 3420675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients.
    Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital.
    Erikstein BS; Hagen KG; Hervig T
    Transfus Med; 2019 Jun; 29(3):169-178. PubMed ID: 29377396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.
    Poornima AP; Fazal S; Shaiji PS; Usha KC; Kailas L
    Indian J Pediatr; 2019 Mar; 86(3):245-249. PubMed ID: 30515703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion and alloimmunization in sickle cell anemia patients].
    Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
    Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.